23andMe CEO says she is no longer open to out­side takeover of­fers

7 months ago
Financing
Deals

Shat­tuck Labs cuts CD47 pro­gram and 40% of work­force as it fo­cus­es on IBD drug

7 months ago
People
R&D

Ron Re­naud's new obe­si­ty biotech, Kail­era, has $400M to go straight to Phase 3

7 months ago
Financing
Startups

Met­sera part­ners with Am­neal to man­u­fac­ture obe­si­ty drugs, and Clive Mean­well hands over CEO role

7 months ago
Startups
Deals

IGM scraps on­col­o­gy work to fo­cus on au­toim­mune, los­es three ex­ec­u­tives

7 months ago
People
R&D

Fed­er­al judge dis­miss­es long­stand­ing suit over Bris­tol My­er­s' $74B Cel­gene buy­out

7 months ago
Pharma
Law

Ap­peals court rules in fa­vor of FDA reg­u­lat­ing cer­tain stem cell clin­ics more strict­ly

7 months ago
FDA+

FDA pledges to take next steps on ad­vi­so­ry com­mit­tee changes

7 months ago
FDA+

Cal­i­for­ni­a's Gavin New­som ve­toes bi­par­ti­san PBM re­form bill

7 months ago
Pharma

J&J pulls the plug on 340B re­bate mod­el changes op­posed by gov­ern­ment

7 months ago
Pharma
FDA+

Up­dat­ed: Pfiz­er to fur­ther de­crease stake in con­sumer health com­pa­ny Ha­le­on

7 months ago
Pharma

En­so­ma shut­ters Copen­hagen site from its Twelve Bio ac­qui­si­tion

7 months ago
People
Startups

Po­sei­da shares in­cre­men­tal Phase 1 up­date for Roche-part­nered off-the-shelf CAR-T

7 months ago
R&D
Cell/Gene Tx

Kezar halts mid-stage lu­pus study af­ter four deaths

7 months ago
R&D

CSPC, Al­pham­ab On­col­o­gy make an ADC deal; Visen’s IPO in Hong Kong

7 months ago
News Briefing

DCVC Bio reels in $400M third fund

7 months ago
Financing
Startups

Rivus de­tails weight loss da­ta in heart fail­ure pa­tients and preps for new fundraise

7 months ago
Startups
R&D

Up­dat­ed: Prime Med­i­cine whit­tles down pipeline, signs gene edit­ing deal with Bris­tol My­ers

7 months ago
Deals
R&D

Up­dat­ed: Roche buys Re­gor’s CDK in­hibitors for $850M up­front amid push to de­vel­op 20 ‘trans­for­ma­tive’ med­i­cines

7 months ago
Deals
R&D

Cereno Sci­en­tif­ic de­tails mid-stage re­sults for pul­monary ar­te­r­i­al hy­per­ten­sion drug

7 months ago
R&D

Lil­ly-part­nered ra­dio­phar­ma start­up Ak­tis On­col­o­gy rais­es $175M

7 months ago
Financing
Startups

Meet this year’s End­points 11; J&J winds down car­dio­vas­cu­lar and meta­bol­ic unit; BMS wins schiz­o­phre­nia ap­proval; ...

7 months ago
Weekly

For some mul­ti­ple myelo­ma pa­tients, Carvyk­ti cut risk of death by 45%

7 months ago
R&D
Pharma

US gov­ern­ment re­news threats over J&J's pro­posed 340B re­bate mod­el

7 months ago
Pharma
FDA+
First page Previous page 88899091929394 Next page Last page
A service from the Financial Times